106 related articles for article (PubMed ID: 2433038)
1. Cisplatin-based treatment of adrenocortical carcinoma.
Hesketh PJ; McCaffrey RP; Finkel HE; Larmon SS; Griffing GT; Melby JC
Cancer Treat Rep; 1987 Feb; 71(2):222-4. PubMed ID: 2433038
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical carcinoma in children: a role for etoposide and cisplatin adjuvant therapy? Preliminary report.
Hovi L; Wikström S; Vettenranta K; Heikkilä P; Saarinen-Pihkala UM
Med Pediatr Oncol; 2003 May; 40(5):324-6. PubMed ID: 12652623
[No Abstract] [Full Text] [Related]
4. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
5. [A case of adrenal cortical carcinoma].
Oida T; Souma T; Doi H; Hida S; Takasu K
Hinyokika Kiyo; 2002 Nov; 48(11):667-70. PubMed ID: 12512139
[TBL] [Abstract][Full Text] [Related]
6. [Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
Ohwada S; Miyamoto Y; Takeshita M; Fujii T; Uchida O; Tanahasi Y; Aoyagi H; Izuo M
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3487-9. PubMed ID: 2802641
[No Abstract] [Full Text] [Related]
7. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
9. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
10. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
Brada M; Horwich A; Peckham MJ
Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of a non-seminomatous germ cell tumor in the seminal vesicle 20 years after initial diagnosis and treatment.
Lattouf JB; Mc Cormack M; Yelle L; Hadjeres R; Saad F
Can J Urol; 2004 Aug; 11(4):2350-1. PubMed ID: 15380057
[TBL] [Abstract][Full Text] [Related]
12. Response of a hepatocellular carcinoma to the cisplatin-vinblastine-bleomycin drug regimen.
Schottinger J; Armentrout S; Slater L; Liao S; McClendon J; Recher L
Cancer Treat Rep; 1984 Nov; 68(11):1419-20. PubMed ID: 6209009
[No Abstract] [Full Text] [Related]
13. Neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Mancuso S; Benedetti Panici P; Greggi S; Scambia G
Contrib Gynecol Obstet; 1989; 17():111-20. PubMed ID: 2468445
[No Abstract] [Full Text] [Related]
14. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study.
Homesley HD; Bundy BN; Hurteau JA; Roth LM
Gynecol Oncol; 1999 Feb; 72(2):131-7. PubMed ID: 10021290
[TBL] [Abstract][Full Text] [Related]
15. Germ cell tumors.
Bajorin DF; Motzer RJ; Bosl GJ
Curr Ther Endocrinol Metab; 1994; 5():354-9. PubMed ID: 7535661
[No Abstract] [Full Text] [Related]
16. [Contribution of chemotherapy in the treatment of cancer of the cavum (UCNT): apropos of 47 cases].
Poupart M; Damiano J; Bolot G; Biron P; Caldentey L; Ardiet JM; Pignat JC
Bull Cancer; 1994 May; 81(5):366-70. PubMed ID: 7538361
[TBL] [Abstract][Full Text] [Related]
17. Adrenal cortical carcinoma: the role of adjuvant postoperative chemotherapy.
Burgess MA
Minerva Endocrinol; 1995 Mar; 20(1):101-4. PubMed ID: 7651278
[No Abstract] [Full Text] [Related]
18. "Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma".
Piver MS
Cancer Treat Rep; 1986 Dec; 70(12):1466. PubMed ID: 3791262
[No Abstract] [Full Text] [Related]
19. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for testicular cancer.
Xiao H; Sheinfeld J; Motzer RJ
Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
